tiprankstipranks
Trending News
More News >
Balchem Corp. (BCPC)
NASDAQ:BCPC
US Market
Advertisement

Balchem (BCPC) Earnings Dates, Call Summary & Reports

Compare
170 Followers

Earnings Data

Report Date
Feb 13, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.18
Last Year’s EPS
1.03
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 21, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance for Balchem Corporation, with record-breaking revenue and growth across all segments. Despite challenges such as increased operating expenses and complex international trade issues, the company continues to demonstrate resilience and strategic growth, particularly in the Human Nutrition and Health and Specialty Products segments.
Company Guidance
During Balchem Corporation's Third Quarter 2025 earnings call, strong financial performance was highlighted with record quarterly consolidated sales of $268 million, reflecting an 11.5% year-over-year increase. The company reported a record quarterly adjusted EBITDA of $71 million, up 11% from the previous year, marking the 25th consecutive quarter of adjusted EBITDA growth. Adjusted net earnings reached $44 million, translating to $1.35 per diluted share, a 19.5% rise from the prior year. The Human Nutrition and Health segment saw a 14.3% sales increase, while the Animal Nutrition and Health segment grew by 6.6%, and Specialty Products by 7.5%. Balchem also maintained a net debt of $89 million with a leverage ratio of 0.3, and an effective tax rate of 22.6%. The outlook remains positive, with continued growth expected in line with favorable market trends.
Record-Breaking Quarterly Financial Performance
Balchem Corporation reported record quarterly consolidated revenue of $268 million, up 11.5% from the prior year, and record quarterly GAAP earnings from operations of $55 million, an increase of 13.7%.
Human Nutrition and Health Segment Growth
The Human Nutrition and Health segment generated record sales of $174 million, an increase of 14.3% from the prior year, driven by strong demand for its unique portfolio of minerals, nutrients, and vitamins.
Animal Nutrition and Health Segment Performance
Generated quarterly sales of $56 million, an increase of 6.6% compared to the prior year, driven by higher sales in both the ruminant and monogastric businesses.
Specialty Products Segment Success
The Specialty Products segment delivered quarterly sales of $36 million, an increase of 7.5% compared to the prior year, driven by higher sales in both the Performance Gases and Plant Nutrition businesses.
Persistent Market Demand and Strategic Growth
Healthy demand across end markets and strategic growth initiatives, including geographic expansion in Plant Nutrition and Performance Gases, contributed to positive results.
Scientific Advancements
Completion of an NIH-funded choline biomarker study, enhancing the ability to assess choline dietary adequacy and supporting market penetration efforts.

Balchem (BCPC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BCPC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 13, 2026
2025 (Q4)
1.18 / -
1.03
Oct 21, 2025
2025 (Q3)
1.16 / 1.24
1.0320.39% (+0.21)
Jul 31, 2025
2025 (Q2)
1.12 / 1.17
1.097.34% (+0.08)
Apr 24, 2025
2025 (Q1)
1.04 / 1.13
1.039.71% (+0.10)
Feb 21, 2025
2024 (Q4)
1.05 / 1.03
0.958.42% (+0.08)
Oct 25, 2024
2024 (Q3)
1.11 / 1.03
1.04-0.96% (-0.01)
Jul 26, 2024
2024 (Q2)
1.03 / 1.09
1.062.83% (+0.03)
May 03, 2024
2024 (Q1)
0.98 / 1.03
0.949.57% (+0.09)
Feb 16, 2024
2023 (Q4)
0.93 / 0.95
0.941.06% (+0.01)
Oct 27, 2023
2023 (Q3)
0.97 / 1.04
14.00% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BCPC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 21, 2025
$150.77$156.89+4.06%
Jul 31, 2025
$152.09$152.47+0.25%
Apr 24, 2025
$158.31$154.20-2.60%
Feb 21, 2025
$161.34$163.73+1.48%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Balchem Corp. (BCPC) report earnings?
Balchem Corp. (BCPC) is schdueled to report earning on Feb 13, 2026, Before Open (Confirmed).
    What is Balchem Corp. (BCPC) earnings time?
    Balchem Corp. (BCPC) earnings time is at Feb 13, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BCPC EPS forecast?
          BCPC EPS forecast for the fiscal quarter 2025 (Q4) is 1.18.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis